JP2023099857A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023099857A5 JP2023099857A5 JP2023087784A JP2023087784A JP2023099857A5 JP 2023099857 A5 JP2023099857 A5 JP 2023099857A5 JP 2023087784 A JP2023087784 A JP 2023087784A JP 2023087784 A JP2023087784 A JP 2023087784A JP 2023099857 A5 JP2023099857 A5 JP 2023099857A5
- Authority
- JP
- Japan
- Prior art keywords
- cellulose
- tablet
- mass
- excipient
- binder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000001913 cellulose Substances 0.000 claims 13
- 229920002678 cellulose Polymers 0.000 claims 12
- 235000010980 cellulose Nutrition 0.000 claims 12
- 239000000654 additive Substances 0.000 claims 9
- 230000000996 additive effect Effects 0.000 claims 9
- 239000011230 binding agent Substances 0.000 claims 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims 5
- 239000000395 magnesium oxide Substances 0.000 claims 4
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims 4
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 2
- 239000011575 calcium Substances 0.000 claims 2
- 229910052791 calcium Inorganic materials 0.000 claims 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 2
- 239000007884 disintegrant Substances 0.000 claims 2
- 239000008187 granular material Substances 0.000 claims 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 claims 1
- 229920002261 Corn starch Polymers 0.000 claims 1
- 229920002785 Croscarmellose sodium Polymers 0.000 claims 1
- 239000001856 Ethyl cellulose Substances 0.000 claims 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 235000001465 calcium Nutrition 0.000 claims 1
- 229950008138 carmellose Drugs 0.000 claims 1
- 239000008120 corn starch Substances 0.000 claims 1
- 229940099112 cornstarch Drugs 0.000 claims 1
- 229960001681 croscarmellose sodium Drugs 0.000 claims 1
- 229960000913 crospovidone Drugs 0.000 claims 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims 1
- 235000019325 ethyl cellulose Nutrition 0.000 claims 1
- 229920001249 ethyl cellulose Polymers 0.000 claims 1
- 238000012812 general test Methods 0.000 claims 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims 1
- 235000019814 powdered cellulose Nutrition 0.000 claims 1
- 229920003124 powdered cellulose Polymers 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 1
- 238000010998 test method Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023087784A JP2023099857A (ja) | 2021-08-20 | 2023-05-29 | 酸化マグネシウム錠剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021134883A JP7340572B2 (ja) | 2021-08-20 | 2021-08-20 | 酸化マグネシウム錠剤 |
| JP2023087784A JP2023099857A (ja) | 2021-08-20 | 2023-05-29 | 酸化マグネシウム錠剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021134883A Division JP7340572B2 (ja) | 2021-08-20 | 2021-08-20 | 酸化マグネシウム錠剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023099857A JP2023099857A (ja) | 2023-07-13 |
| JP2023099857A5 true JP2023099857A5 (enExample) | 2024-08-22 |
Family
ID=85240721
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021134883A Active JP7340572B2 (ja) | 2021-08-20 | 2021-08-20 | 酸化マグネシウム錠剤 |
| JP2023087784A Pending JP2023099857A (ja) | 2021-08-20 | 2023-05-29 | 酸化マグネシウム錠剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021134883A Active JP7340572B2 (ja) | 2021-08-20 | 2021-08-20 | 酸化マグネシウム錠剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250127725A1 (enExample) |
| EP (1) | EP4389133A4 (enExample) |
| JP (2) | JP7340572B2 (enExample) |
| CN (1) | CN117835990A (enExample) |
| TW (1) | TW202322827A (enExample) |
| WO (1) | WO2023022078A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7742381B2 (ja) * | 2023-06-21 | 2025-09-19 | セトラスホールディングス株式会社 | 錠剤の製造方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4015485B2 (ja) * | 2001-08-27 | 2007-11-28 | 協和化学工業株式会社 | 制酸・緩下用錠剤 |
| AR065096A1 (es) * | 2007-02-01 | 2009-05-13 | Takeda Pharmaceutical | Preparacion solida |
| JP5499599B2 (ja) * | 2008-10-01 | 2014-05-21 | 大正製薬株式会社 | アセトアミノフェン含有錠剤 |
| WO2011030659A1 (ja) * | 2009-09-08 | 2011-03-17 | 協和化学工業株式会社 | 制酸・緩下用錠剤 |
| TWI564008B (zh) * | 2010-09-30 | 2017-01-01 | 鹽野義製藥股份有限公司 | 難溶性藥物之溶解性改善製劑 |
| US10166219B2 (en) * | 2012-07-27 | 2019-01-01 | Redhill Bipharma Ltd. | Formulations and methods of manufacturing formulations for use in colonic evacuation |
| KR20150019620A (ko) * | 2013-08-14 | 2015-02-25 | 삼성디스플레이 주식회사 | 유기발광 표시 장치 |
| JP6182023B2 (ja) * | 2013-08-30 | 2017-08-16 | アサヒグループ食品株式会社 | 酸化マグネシウム含有錠剤及びその製造方法 |
| TWI724629B (zh) * | 2018-11-16 | 2021-04-11 | 日商協和化學工業股份有限公司 | 緩瀉用錠劑 |
-
2021
- 2021-08-20 JP JP2021134883A patent/JP7340572B2/ja active Active
-
2022
- 2022-08-09 CN CN202280056422.3A patent/CN117835990A/zh active Pending
- 2022-08-09 EP EP22858399.3A patent/EP4389133A4/en active Pending
- 2022-08-09 WO PCT/JP2022/030484 patent/WO2023022078A1/ja not_active Ceased
- 2022-08-09 US US18/685,051 patent/US20250127725A1/en active Pending
- 2022-08-15 TW TW111130617A patent/TW202322827A/zh unknown
-
2023
- 2023-05-29 JP JP2023087784A patent/JP2023099857A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010121135A (ru) | Лекарственные формы для перорального применения, содержащие ацетат ликарбазепина | |
| JP2023099857A5 (enExample) | ||
| JP2019108324A (ja) | リバーロキサバン含有医薬組成物 | |
| JP2018118966A5 (enExample) | ||
| CN101647785A (zh) | 格列齐特缓释片及其制备方法 | |
| SE509694C2 (sv) | Farmaceutiska kompositioner innehållande ranitidin/vismut karboxylsyra salter | |
| JP2002522377A5 (enExample) | ||
| TW201318650A (zh) | 口崩片組成物 | |
| EP2067470A1 (en) | Pharmaceutical compositions containing valsartan and process for its preparation | |
| JP6271802B1 (ja) | 口腔内崩壊錠 | |
| EP1556050A1 (en) | Pharmaceutical compositions of ganciclovir | |
| JP6883401B2 (ja) | アジルサルタン含有錠剤及び錠剤におけるアジルサルタンの安定化方法 | |
| JP2018127417A (ja) | フェブキソスタット含有口腔内崩壊錠 | |
| JP2017001973A (ja) | イルベサルタン含有錠剤 | |
| JP7101464B2 (ja) | アジルサルタン又はその塩及びアムロジピン又はその塩含有錠剤の品質向上方法、並びにアジルサルタン又はその塩及びアムロジピン又はその塩含有錠剤及びその製造方法 | |
| JP6601844B2 (ja) | 光安定性に優れたミルタザピン含有医薬製剤 | |
| JP6176246B2 (ja) | 固形医薬錠剤およびその製造方法 | |
| JP2020083887A (ja) | アジルサルタンを含有する錠剤 | |
| JP4438043B2 (ja) | 経時的な溶出速度低下を抑制した医薬組成物 | |
| JP6037687B2 (ja) | グリメピリドを含有する口腔内崩壊錠 | |
| KR102350374B1 (ko) | 간 건강에 도움을 주는 밀크씨슬을 고함량으로 포함하며 붕해성이 개선된 정제 | |
| CN100455288C (zh) | 一种盐酸雷诺嗪制剂配方 | |
| CN1943787B (zh) | 一种药物防潮组合物及其制备方法 | |
| JP2019089758A (ja) | セレコキシブ含有錠剤における溶出性の改善方法 | |
| RU2021132040A (ru) | Твердая фармацевтическая композиция, содержащая агонист tlr7 |